Saying yes to Cookies

By clicking “Yes, please” to cookies, you’re helping us improve your experience on our site. Cookies help us understand what works well and what could be improved, and they help us tailor what you see to your interests. For more details, see our Cookie and Privacy Policy.

No, thanks
Yes, please
Preferences
COOKIE AND PRIVACY PREFERENCES
Essential cookies
REQUIRED
Marketing cookies
Personalization cookies
Analytics cookies

For more details, see our Cookie and Privacy Policy.

Reject all cookiesAllow all cookies
Careers
Contact
AboutBioAlternativesScience and TechnologyPrograms and ServicesInsights and News

Accelerating the Transition
to BioAlternatives

Manufacturing many of today’s everyday products is resource intensive and comes with a heavy environmental cost.

We enable companies across industries to replace existing ingredients, materials, and chemicals with bioalternatives, increasing supply security while reducing environmental impacts.

What are BioAlternatives?

Bioalternatives are more sustainable versions of molecules traditionally sourced through environmentally harmful means, such as petrochemical or agricultural extraction, and animal husbandry.

The microbe and the microbial cell factory are at the core of our work – providing the engine of efficiency

Using synthetic biology, we can harness the power of engineered cell factories to produce bioalternatives cost-effectively, reliably, and sustainably – for use in a wide range of everyday products.

The benefits of BioAlternatives,
Made by Manus™

More Sustainable
Less resource intensive
Less land use
Less energy
Less water
Less CO2
Tractor field
Tincture
Better Performing
Increased traceability
Higher quality
Higher purity
More affordable
Stable supply

The World's
Leading BioAlternatives Scale-up Platform

Our proven scale-up platform spans the entire process, from cell factory design and engineering to biomanufacturing at scale. This allows companies to accelerate the adoption of bioalternatives and deliver them to market seamlessly.

Just like Nature,
Made by ManusTM

01

Multiple commercialized products demonstrate our ability to bridge the Valley of Death and deliver bioalternatives quickly and efficiently.

Some recent examples:

  • BioSweeteners such as BioStevia (Reb M) as part of The Natural Sweetener Alliance with Tate & Lyle – Better taste, more sustainable
  • BioIngredients like our Nootkatone 70 and Valencene 80, and BioNootkatone developed, scaled, and manufactured for Givaudan – Lower cost, more sustainable

State-of-the-Art
BioFacilities

02

With sophisticated cell factory engineering, advanced piloting, and large-scale capabilities, our BioFacilities ensure we can deliver the benefits of SynBio, no matter the scale-up or capacity challenge.

A Team of Experts,
Always on Hand

03

Our passionate multidisciplinary team of experts is always ready to help your company realize the benefits of bioalternatives – systematically and cost-efficiently.

Our scale-up platform delivers the benefits of synthetic biology, at manufacturing scale, today.

        Colleagues inspecting equipment
at our Augusta BioFacility               

Manus colleagues inspecting centrifuge vessels at our Augusta BioFacility

Scientist at our analytical lab in Augusta, Georgia

Manus colleagues inspecting centrifuge vessels at our Augusta BioFacility

Expertise
at Every Step

Unique expertise goes into each step of the development and scale-up process. This enables us to accelerate the creation and optimization of cell factories to perform complex chemistries at scale.

Discover our proven
scale-up platform.

Let’s scale your vision together!

Get in touch

Contact

Get in touch+1 706 303 5600

Social

LinkedInX

INDEX

AboutBioAlternativesScience and TechnologyPrograms and ServicesInsights and NewsCareers

Stay connected with manus

Thank you for being part of the transition. Stay tuned!
Sorry for the snafu. Please try submitting the form again.

© 2025 Manus Bio Inc.  All Rights Reserved.

Terms and Conditions
Cookie and Privacy Policy
Copyright
Manus and Inscripta merge to create a leader in industrial biomanufacturing
Manus applauds NSCEB recommendations and calls for urgent national strategy on biomanufacturing
Manus awarded $32.4 million in government funding to boost domestic production of critical medicines
Joint Press Release
April 16, 2025

Manus and Inscripta merge to create a leader in industrial biomanufacturing

Combined company to leverage cutting-edge end-to-end platform and domestic manufacturing to accelerate commercialization of bioalternative products.

Read more >
Press Release
April 8, 2025

Manus applauds NSCEB recommendations and calls for urgent national strategy on biomanufacturing

CEO highlights need for coordinated federal action to accelerate U.S. bioeconomy leadership.

Read more >
Press Release
November 26, 2024

Manus awarded $32.4 million in government funding to boost domestic production of critical medicines

With the funding, the company will establish key infrastructure to produce natural product drugs at population-scale, including critical anti-malaria therapies, and reduce U.S. reliance on foreign sources.

Read more >